Used in research to selectively inhibit FGFR1 and DDR2 tyrosine kinases, this compound helps study signaling pathways involved in cell growth and differentiation. It is applied in cancer research, particularly in models where FGFR1 or DDR2 overexpression contributes to tumor progression, such as certain lung, breast, and gastric cancers. By blocking these kinases, it aids in evaluating downstream effects on cell proliferation, survival, and migration. Also used as a tool compound to assess the therapeutic potential of dual FGFR1/DDR2 inhibition and to support the development of more advanced kinase inhibitors.